Metformin in breast cancer - an evolving mystery

Abstract

Metformin, a diabetes drug with well-established side effect and safety profiles, has been widely studied for its anti-tumor activities in a number of cancers, including breast cancer. But its mechanism of action in the clinical arena remains elusive. In a window of opportunity trial of metformin in non-diabetic breast cancer patients, Dowling and… (More)
DOI: 10.1186/s13058-015-0598-8

Topics

1 Figure or Table

Cite this paper

@inproceedings{Camacho2015MetforminIB, title={Metformin in breast cancer - an evolving mystery}, author={Laura Camacho and Atreyi Dasgupta and Sao Jiralerspong}, booktitle={Breast Cancer Research}, year={2015} }